Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Orvosi Hetilap|February 4, 2020
[Percutaneous ethanol injection efficacy in the treatment of benign thyroid nodules. Ten-year follow-up of 254 patients]Tamás SolymosiOrvosi Hetilap|September 13, 2002
[Percutaneous ethanol sclerotherapy of non-toxic nodular goiters--a clinical study of 76 patients]Tamás SolymosiMagyar Sebeszet|October 23, 2013
[Effectiveness and safety of total thyroidectomy in the management of benign multinodular goiters]István Gál, Tamás Solymosi, Gyula Lukács-Tóth, et al.Magyar Sebeszet|January 5, 2007
[Minimally invasive video-assisted thyroidectomy (MIVAT)]István Gál, Tamás Solymosi, Alexander Bálint, et al.Thyroid : Official Journal of the American Thyroid Association|September 13, 2002
Influence of iodine intake on the diagnostic power of fine-needle aspiration cytology of the thyroid glandTamás Solymosi, Gyula Lukács Tóth, Istvan Gál, et al.European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|October 29, 2013
Novel continuous flow technology for the development of a nanostructured aprepitant formulation with improved pharmacokinetic propertiesRéka Angi, Tamás Solymosi, Zsolt Ötvös, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 6, 2019
Investigations of the mechanism behind the rapid absorption of nano-amorphous abiraterone acetateOrsolya Basa-Dénes, Tamás Solymosi, Zsolt Ötvös, et al.European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 25, 2015
Sirolimus formulation with improved pharmacokinetic properties produced by a continuous flow methodTamás Solymosi, Réka Angi, Orsolya Basa-Dénes, et al.International Journal of Pharmaceutics|September 19, 2017
Development of an abiraterone acetate formulation with improved oral bioavailability guided by absorption modeling based on in vitro dissolution and permeability measurementsTamás Solymosi, Zsolt Ötvös, Réka Angi, et al.Cancer Chemotherapy and Pharmacology|August 5, 2017
Novel formulation of abiraterone acetate might allow significant dose reduction and eliminates substantial positive food effectTamás Solymosi, Zsolt Ötvös, Réka Angi, et al.Pageof 2